CynergisTek to provide additional support in safeguarding sensitive information to a top leader in children’s health
AUSTIN, TX (June 7, 2022) – CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces a six-figure extension contract for a west coast pediatric healthcare system for risk assessment, promoting interoperability security controls assessment, vendor security management, and incident response readiness services.
Healthcare organizations are becoming increasingly aware of the need to ensure greater due diligence in understanding their security posture and risks faced across the enterprise, increasing their ability to respond and handle security incidents, managing the risks posed by vendors, and remaining compliant with ever increasing regulatory obligations. The industry is moving past building programs and implementing controls to wanting to know that their investments and efforts are effectively blocking threats. This client continues to rely on CynergisTek’s expertise and array of capabilities to assist in managing risk.
“Understanding cybersecurity risk to an organization is a critical and a necessary part of ensuring the impacts of disruptive cyber-attacks are minimal,” said Dave Bailey, Vice President of Security Services at CynergisTek. “Proactive risk assessment and risk management help build resilient and effective safeguards,” he adds.
In today’s IT environment, the attack surface encompasses an organization’s information assets, whether on-premise, hosted, or provided by a third-party externally. Being prepared for cyber incidents takes a combination of active defenses, smart actions, and solid response plans and execution. “The muscle memory needed to thwart an attack is no trivial matter, and more organizations are looking for experienced outside partners to assist them in exercising and developing this expertise,” said Mac McMillan, CEO of CynergisTek. “Combining the first-hand knowledge of our teams with the tools of strategic partners like GroupSense, Awake, and Mandiant, to name a few, provides our clients with the expertise they need to accomplish this task.” This is a relatively new set of solutions and services that are catching on with the market.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit cynergistek.com or follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of the COVID-19 pandemic, including actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets; the general economic impact of the ongoing war in Ukraine, including the impact of related sanctions being imposed by the U.S. Government and the governments of other countries, and the impact of potential reprisals as a consequence of the war in Ukraine and any related sanctions; and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry, or the ongoing war in Ukraine. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
CynergisTek Investor Relations Contact:
(512) 402-8550 x7
CynergisTek Media Contact: